Association Between Payer Type and Risk of Persistent Opioid Use After Surgery.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
01 12 2023
01 12 2023
Historique:
medline:
9
11
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
To assess whether the risk of persistent opioid use after surgery varies by payer type. Persistent opioid use is associated with increased health care utilization and risk of opioid use disorder, opioid overdose, and mortality. Most research assessing the risk of persistent opioid use has focused on privately insured patients. Whether this risk varies by payer type is poorly understood. This cross-sectional analysis of the Michigan Surgical Quality Collaborative database examined adults aged 18 to 64 years undergoing surgical procedures across 70 hospitals between January 1, 2017 and October 31, 2019. The primary outcome was persistent opioid use, defined a priori as 1+ opioid prescription fulfillment at (1) an additional opioid prescription fulfillment after an initial postoperative fulfillment in the perioperative period or at least 1 fulfillment in the 4 to 90 days after discharge and (2) at least 1 opioid prescription fulfillment in the 91 to 180 days after discharge. The association between this outcome and payer type was evaluated using logistic regression, adjusting for patient and procedure characteristics. Among 40,071 patients included, the mean age was 45.3 years (SD 12.3), 24,853 (62%) were female, 9430 (23.5%) were Medicaid-insured, 26,760 (66.8%) were privately insured, and 3889 (9.7%) were covered by other payer types. The rate of POU was 11.5% and 5.6% for Medicaid-insured and privately insured patients, respectively (average marginal effect for Medicaid: 2.9% (95% CI 2.3%-3.6%)). Persistent opioid use remains common among individuals undergoing surgery and higher among patients with Medicaid insurance. Strategies to optimize postoperative recovery should focus on adequate pain management for all patients and consider tailored pathways for those at risk.
Sections du résumé
OBJECTIVE
To assess whether the risk of persistent opioid use after surgery varies by payer type.
BACKGROUND
Persistent opioid use is associated with increased health care utilization and risk of opioid use disorder, opioid overdose, and mortality. Most research assessing the risk of persistent opioid use has focused on privately insured patients. Whether this risk varies by payer type is poorly understood.
METHODS
This cross-sectional analysis of the Michigan Surgical Quality Collaborative database examined adults aged 18 to 64 years undergoing surgical procedures across 70 hospitals between January 1, 2017 and October 31, 2019. The primary outcome was persistent opioid use, defined a priori as 1+ opioid prescription fulfillment at (1) an additional opioid prescription fulfillment after an initial postoperative fulfillment in the perioperative period or at least 1 fulfillment in the 4 to 90 days after discharge and (2) at least 1 opioid prescription fulfillment in the 91 to 180 days after discharge. The association between this outcome and payer type was evaluated using logistic regression, adjusting for patient and procedure characteristics.
RESULTS
Among 40,071 patients included, the mean age was 45.3 years (SD 12.3), 24,853 (62%) were female, 9430 (23.5%) were Medicaid-insured, 26,760 (66.8%) were privately insured, and 3889 (9.7%) were covered by other payer types. The rate of POU was 11.5% and 5.6% for Medicaid-insured and privately insured patients, respectively (average marginal effect for Medicaid: 2.9% (95% CI 2.3%-3.6%)).
CONCLUSIONS
Persistent opioid use remains common among individuals undergoing surgery and higher among patients with Medicaid insurance. Strategies to optimize postoperative recovery should focus on adequate pain management for all patients and consider tailored pathways for those at risk.
Identifiants
pubmed: 37334751
doi: 10.1097/SLA.0000000000005937
pii: 00000658-202312000-00040
pmc: PMC10631504
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1185-e1191Subventions
Organisme : NIDA NIH HHS
ID : K08 DA048110
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA042859
Pays : United States
Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Ahmad FB, Cisewski JA, Rossen LM, et al. Provisional drug overdose death counts. Hyattsville, MD: National Center for Health Statistics; 2022. August 18, 2022. Accessed September 11. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation
Bateman BT, Franklin JM, Bykov K, et al. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women. Am J Obstet Gynecol. 2016;215:353.e1–353.e18.
Waljee JF, Li L, Brummett CM, et al. Iatrogenic opioid dependence in the United States: Are surgeons the gatekeepers? Ann Surg. 2017;265:728–730.
Brummett CM, Waljee JF, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US Adults. JAMA Surg. 2017;152:e170504.
Thiels CA, Anderson SS, Ubl DS, et al. Wide variation and overprescription of opioids after elective surgery. Ann Surg. 2017;266:564–573.
Hill MV, McMahon ML, Stucke RS, et al. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265:709–714.
Howard R, Fry B, Gunaseelan V, et al. Association of opioid prescribing with opioid consumption after surgery in Michigan. JAMA Surg. 2019;154:e184234.
Babu KM, Brent J, Juurlink DN. Prevention of opioid overdose. N Engl J Med. 2019;380:2246–2255.
Brummett CM, Evans-Shields J, England C, et al. Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients. JMCP. 2021;27:760–771.
Brescia AA, Waljee JF, Hu HM, et al. Impact of prescribing on new persistent opioid use after cardiothoracic surgery. Ann Thorac Surg. 2019;108:1107–1113.
Aalberg JJ, Kimball MD, McIntire TR, et al. Long-term outcomes of persistent post-operative opioid use: a retrospective cohort study. Ann Surg. 2022. doi: 10.1097/SLA.0000000000005372
doi: 10.1097/SLA.0000000000005372
Wilton J, Abdia Y, Chong M, et al. Purssell R. Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study. BMJ. 2021;375:e066965.
Elm Ev, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–1457.
Healy MA, Regenbogen SE, Kanters AE, et al. Surgeon Variation in Complications With Minimally Invasive and Open Colectomy. JAMA Surg. 2017;152:860–867.
Campbell DA Jr, Kubus JJ, Henke PK, et al. The Michigan Surgical Quality Collaborative: a legacy of Shukri Khuri. Am J Surg. 2009;198(5 Suppl):S49–S55.
Chua KP, Hu HM, Waljee JF, et al. Persistent opioid use associated with dental opioid prescriptions among publicly and privately insured US patients, 2014 to 2018. JAMA Netw Open. 2021;4:e216464.
Medicaid and the Opioid Epidemic. MACPAC . Accessed November 13, 2022: https://www.macpac.gov/publication/medicaid-and-the-opioid-epidemic/
Howard R, Brown CS, Lai Y-L, et al. Postoperative opioid prescribing and new persistent opioid use: the risk of excessive prescribing. Ann Surg. 2022;277:e1225–e1231.
Bicket MC, Gunaseelan V, Lagisetty P, et al. Association of opioid exposure before surgery with opioid consumption after surgery. Reg Anesth Pain Med. 2022;47:346–352.
Barth RJ Jr, Porter ED, Kelly JL, et al. Reasons for long-term opioid prescriptions after guideline-directed opioid prescribing and excess opioid pill disposal. Ann Surg. 2023;277:173–178.
Lawal OD, Gold J, Murthy A, et al. Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Network Open. 2020;3:e207367.
Waljee JF, Cron DC, Steiger RM, et al. Effect of preoperative opioid exposure on healthcare utilization and expenditures following elective abdominal surgery. Ann Surg. 2017;265:715–721.
Stark N, Kerr S, Stevens J. Prevalence and predictors of persistent post-surgical opioid use: a prospective observational cohort study. Anaesth Intensive Care. 2017;45:700–706.
Hilliard PE, Waljee J, Moser S, et al. Prevalence of preoperative opioid use and characteristics associated with opioid use among patients presenting for surgery. JAMA Surg. 2018;153:929–937.
Huang Y, Jacobson JS, Tergas AI, et al. Insurance-associated disparities in opioid use and misuse among patients undergoing gynecologic surgery for benign indications. Obstet Gynecol. 2020;136:565–575.
Lockett MA, Ward RC, McCauley JL, et al. New chronic opioid use in Medicaid patients following cholecystectomy. Surgery Open Science. 2022;9:101–108.
Samples H, Williams AR, Olfson M, et al. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. J Subst Abuse Treat. 2018;95:9–17.
Mikosz CA, Zhang K, Haegerich T, et al. Indication-specific opioid prescribing for US Patients with medicaid or private insurance, 2017. JAMA Netw Open. 2020;3:e204514.